Friday 6 November 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue: +5.52%
EPS: +258.4%
Free cash flow: −7.81%
Total debt: +47.1%

Quarter to September 2026, against a year earlier

335.37 4.31 −1.27%

Follow COR

Alert me

Market cap: $64.8B
P/E: 18.8×
Fwd P/E: 17.5×
Dividend yield: 0.71%
F-score: 7/9
Altman Z: n/a
Beneish M: −2.59
Dividend safety: 70/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Cencora, Inc. 10-Q filed May 6, 2026

Fiscal Q2 2026 · Period ended Mar 31, 2026 · Filed May 6, 2026 · accepted 2:41 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Feb 4, 2026: no changes